NVO

Novo Nordisk A/S

1 day chart

About NVO

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Market Capitalisation

$351.55B

Price-earnings ratio

Dividend yield

0.50%

Volume

158.61K

High today

$101.99

Low today

$101.01

Open price

$0.00

52-week high

$105.69

52-week low

$62.41

NVO FAQs

Can I buy NVO shares through Stake, an investing platform like Sharesies and Hatch Invest?

Yes, the Stake platform allows you to buy NVO shares and over 6,000 stocks and ETFs on Wall St.

How much is one share of Novo Nordisk A/S?

One share of Novo Nordisk A/S is valued at $101.93.

What is the ticker symbol for Novo Nordisk A/S?

The ticker symbol for Novo Nordisk A/S is NVO.

How do I buy NVO shares in Australia?

To buy NVO stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in NVO

What is the 52-week high for Novo Nordisk A/S stock?

The Novo Nordisk A/S 52-week high stock price is $105.69.

What is the 52-week low for Novo Nordisk A/S stock?

The Novo Nordisk A/S 52-week low stock price is $62.41.

What is the market capitalisation of Novo Nordisk A/S NVO?

As of 01/12/2023 Novo Nordisk A/S has a market cap of $352B.

Related Stocks

This content does not constitute financial advice and has not been prepared to take into account your individual circumstances. As investments carry risk, you should do your own research and consider getting advice from a licensed tax or financial advisor before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.